Monitor for any future amendments to this 13G or a conversion to 13D, which would signal a change in intent. The passive nature of this filing suggests no immediate activist engagement.
Price Chart
Executive Summary
Coastlands Capital LP and related entities filed a Schedule 13G disclosing a 5.69% passive stake in Kalaris Therapeutics, Inc., representing 1,355,119 shares of common stock. The filing certifies that the securities were acquired in the ordinary course of business and not with the purpose of changing or influencing control of the issuer.
Key Financial Metrics
Key Facts
- Coastlands Capital LP and related entities filed a Schedule 13G on October 26, 2026.
- The filing discloses beneficial ownership of 1,355,119 shares of Kalaris Therapeutics common stock.
- The stake represents 5.69% of shares outstanding, based on 23,804,981 shares outstanding as of August 4, 2026.
- The filing certifies passive intent under Rule 13d-1(b) and Rule 13d-1(c).
- The shares are held directly by Coastlands Capital Partners LP.
- Matthew D. Perry is the control person of the reporting entities.
Financial Impact
Passive 5.69% stake valued at approximately $2.7 million based on $47M market cap.
Risk Factors
- No specific risks identified from this passive stake disclosure.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001104659-26-118876 |
| Document: 0001104659-26-118876-index-headers.html | 0001104659-26-118876 |
| Document: 0001104659-26-118876-index.html | 0001104659-26-118876 |
| Document: 0001104659-26-118876.txt | 0001104659-26-118876 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | SC 13G | $1.80 | awaiting T+60 | — | $1.86 (+3.33%) |
Aug 11, 2026 11w ago | 8-K | $3.97 | awaiting T+60 | — | $1.86 (−53.15%) |
Aug 11, 2026 11w ago | Press Release | $3.97 | awaiting T+60 | — | $1.86 (−53.15%) |
Aug 3, 2026 12w ago | 3 | $4.32 | awaiting T+60 | — | $1.86 (−56.94%) |
Jul 20, 2026 14w ago | 8-K | $4.00 $2.23 | ▼ −44.25% | ▼ −49.09% | $1.86 (−53.50%) |
Jul 17, 2026 14w ago | 8-K | $4.38 $2.26 | ▼ −48.40% | ▼ −53.09% | $1.86 (−57.53%) |
Jul 17, 2026 14w ago | Press Release | $4.38 $2.26 | ▼ −48.40% | ▼ −53.09% | $1.86 (−57.53%) |
Jun 11, 2026 19w ago | Institutional Cluster | $4.36 $3.90 | ▼ −10.55% | ▼ −14.95% | $1.86 (−57.34%) |
May 12, 2026 24w ago | 8-K | $4.79 $4.19 | ▼ −12.53% | ▼ −16.91% | $1.86 (−61.17%) |
May 12, 2026 24w ago | Press Release | $4.79 $4.19 | ▼ −12.53% | ▼ −16.91% | $1.86 (−61.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers